Revogene® SARS-CoV-2

A real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) test run on the Revogene® instrument for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab (NPS) specimens collected from individuals suspected of having a COVID-19 infection.

Catalog Number: 410700

Support & Documents

Why Revogene SARS-CoV-2?

Revogene is a fully automated molecular platform that features single and multiplex testing capabilities with minimal hands-on time. It’s a flexible, scalable platform that is built to grow with you.

  • Group 12 Created with Sketch.
    Streamlined and time-saving workflow in just 2 steps with 1 minute of hands-on-time
  • assay_flexibility_icon
    Walk-away efficiencies with early positive results as early as 47 minutes
  • Group 19 Created with Sketch.
    Can optimize testing capacity and deliver near-patient testing capabilities

It’s minimal hands-on-time with Revogene.
Samples in and walk away.

Minimal workflow. Minimal hands-on time.

Definitive answers, confidence in results

Contact Sales

Definitive answers, confidence in results

Contact Sales

Support & Documents

Downloadable PDFs

  • This test has not been FDA cleared or approved.
  • Validation of this test has not been reviewed by FDA.  Review under the EUA program is pending.
  • Results of the Revogene SARS-CoV-2 test should be used in conjunction with other clinical and laboratory findings, including patient history to determine patient infection status. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions.

Get in touch with us

Contact Us

Welcome to

Please select your country to continue